Literature DB >> 28729298

Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults.

Maan Moualla1, Clifford Qualls2, Alexander Arynchyn3, Bharat Thyagarajan4, Ravi Kalhan5, Lewis J Smith5, John J Carr6, David R Jacobs7, Akshay Sood1.   

Abstract

RATIONALE: Adiposity is associated with low lung function, but the longitudinal relationship between lung function and adiposity is inadequately studied.
OBJECTIVE: To examine the bidirectional longitudinal associations between rapid decline in lung function and adiposity phenotypes in healthy adults.
METHODS: This secondary analysis used a 25-year longitudinal dataset from the Coronary Artery Risk Development in Young Adults (CARDIA) study that enrolled 5115 participants. MEASUREMENTS: In the first analysis, metabolic syndrome at or before CARDIA year (Y) 10 (Y10) was the predictor, and subsequent rapid decline in forced vital capacity (FVC) or forced expiratory volume in 1 s (FEV1) between Y10 and Y20 was the outcome. In the second analysis, rapid decline was the predictor, and incident metabolic syndrome at Y20 and/or Y25 was the outcome. In the third analysis, rapid decline was the predictor, and subsequent CT-assessed regional fat depots at Y25 were the outcome.
RESULTS: Metabolic syndrome at or before Y10 is temporally associated with rapid decline in FVC between Y10 and Y20 (adjusted p=0.04), but this association was explained by body mass index (BMI) at Y10. Rapid decline in FVC or FEV1 is temporally associated with greater incident metabolic syndrome at Y20 and/or Y25 (adjusted OR 2.10 (1.69, 2.61); p<0.001, and 1.56 (1.26, 1.94); p<0.001, respectively) and greater CT-assessed intrathoracic visceral adiposity at Y25 (adjusted standardised β 0.09; p<0.001 for both analyses). These associations were not explained by BMI levels prior to the outcome measurement.
CONCLUSIONS: Healthy adults with rapid decline in lung function are at risk for developing metabolic syndrome and for disproportionate accumulation of intrathoracic visceral fat. Metabolic abnormalities may be an early extrapulmonary manifestation of lung impairment that may be preventable by improving lung health. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Body mass index; metabolic syndrome; visceral fat

Mesh:

Year:  2017        PMID: 28729298      PMCID: PMC6158777          DOI: 10.1136/thoraxjnl-2016-209125

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.102


  49 in total

1.  Low vital capacity was found to be associated with incident diabetes in health screening population of Japanese women.

Authors:  Eiji Oda
Journal:  Intern Med       Date:  2014-11-01       Impact factor: 1.271

2.  Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study.

Authors:  G Engström; B Hedblad; P Nilsson; P Wollmer; G Berglund; L Janzon
Journal:  J Intern Med       Date:  2003-05       Impact factor: 8.989

3.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties.

Authors:  J M Marchington; C A Mattacks; C M Pond
Journal:  Comp Biochem Physiol B       Date:  1989

4.  Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.

Authors:  Gerd Assmann; Rudy Guerra; Garrett Fox; Paul Cullen; Helmut Schulte; DuWayne Willett; Scott M Grundy
Journal:  Am J Cardiol       Date:  2007-01-02       Impact factor: 2.778

5.  Lung function changes in older people with metabolic syndrome and diabetes.

Authors:  Simone Scarlata; Filippo Luca Fimognari; Matteo Cesari; Renato Giua; Alessandro Franco; Patrizio Pasqualetti; Ruggero Pastorelli; Raffaele Antonelli-Incalzi
Journal:  Geriatr Gerontol Int       Date:  2013-01-14       Impact factor: 2.730

6.  Association of lung function measurements and visceral fat in men with metabolic syndrome.

Authors:  Willemien Thijs; Reza Alizadeh Dehnavi; Pieter S Hiemstra; Albert de Roos; Christian F Melissant; Kirsten Janssen; Jouke T Tamsma; Klaus F Rabe
Journal:  Respir Med       Date:  2013-10-10       Impact factor: 3.415

7.  Association of circulating adhesion molecules with lung function. The CARDIA study.

Authors:  Bharat Thyagarajan; Lewis J Smith; R Graham Barr; Myron D Gross; Akshay Sood; Ravi Kalhan; David R Jacobs
Journal:  Chest       Date:  2009-02-18       Impact factor: 9.410

Review 8.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  Rubin M Tuder; Irina Petrache
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

9.  Longitudinal association of body mass index with lung function: the CARDIA study.

Authors:  Bharat Thyagarajan; David R Jacobs; George G Apostol; Lewis J Smith; Robert L Jensen; Robert O Crapo; R Graham Barr; Cora E Lewis; O Dale Williams
Journal:  Respir Res       Date:  2008-04-04

Review 10.  Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat.

Authors:  Dukhabandhu Naik; Anjali Joshi; Thomas Vizhalil Paul; Nihal Thomas
Journal:  Indian J Endocrinol Metab       Date:  2014-09
View more
  7 in total

1.  Validation of Predictive Metabolic Syndrome Biomarkers of World Trade Center Lung Injury: A 16-Year Longitudinal Study.

Authors:  Sophia Kwon; George Crowley; Erin J Caraher; Syed Hissam Haider; Rachel Lam; Arul Veerappan; Lei Yang; Mengling Liu; Rachel Zeig-Owens; Theresa M Schwartz; David J Prezant; Anna Nolan
Journal:  Chest       Date:  2019-03-02       Impact factor: 9.410

Review 2.  Visceral adiposity and respiratory outcomes in children and adults: a systematic review.

Authors:  Tong Wu; Marc R Jahangir; Sara M Mensink-Bout; Stefan Klein; Liesbeth Duijts; Edwin H G Oei
Journal:  Int J Obes (Lond)       Date:  2022-02-21       Impact factor: 5.551

3.  A Dyadic Growth Modeling Approach for Examining Associations Between Weight Gain and Lung Function Decline.

Authors:  Talea Cornelius; Joseph E Schwartz; Pallavi Balte; Surya P Bhatt; Patricia A Cassano; David Currow; David R Jacobs; Miriam Johnson; Ravi Kalhan; Richard Kronmal; Laura Loehr; George T O'Connor; Benjamin Smith; Wendy B White; Sachin Yende; Elizabeth C Oelsner
Journal:  Am J Epidemiol       Date:  2020-10-01       Impact factor: 4.897

Review 4.  Lung function and cardiovascular disease: A link.

Authors:  Sergio H R Ramalho; Amil M Shah
Journal:  Trends Cardiovasc Med       Date:  2020-01-03       Impact factor: 6.677

5.  Association between Cardiorespiratory Fitness and Bronchiectasis at CT: A Long-term Population-based Study of Healthy Young Adults Aged 18-30 Years in the CARDIA Study.

Authors:  Alejandro A Diaz; Laura A Colangelo; Yuka Okajima; Andrew Yen; Marc A Sala; Mark T Dransfield; Gregory Tino; James C Ross; Raúl San José Estépar; George R Washko; Ravi Kalhan
Journal:  Radiology       Date:  2021-04-27       Impact factor: 29.146

6.  Lung Function in Young Adults and Risk of Cardiovascular Events Over 29 Years: The CARDIA Study.

Authors:  Michael J Cuttica; Laura A Colangelo; Mark T Dransfield; Surya P Bhatt; Jamal S Rana; David R Jacobs; Bharat Thyagarajan; Stephen Sidney; Cora E Lewis; Kiang Liu; Donald Lloyd-Jones; George Washko; Ravi Kalhan
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

7.  Glomerular hyperfiltration may be a novel risk factor of restrictive spirometry pattern: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2015.

Authors:  Hong Il Lim; Sang Jin Jun; Sung Woo Lee
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.